Tigenix NV logo

TIG - Tigenix NV Share Price

€1.78 0.0  0.2%

Last Trade - 26/07/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 847
Bullish
Bearish
Unlock TIG Revenue
Momentum
Relative Strength (%)
1m -0.74%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
4.08 0.88 6.29 2.24 25.4 0.000 23.9 4.95 -100.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2017, TigenixNV revenues decreased from EUR25.4M to EUR0K. Net losstotaled EUR74.8M vs. income of EUR3.8M. Revenues reflectBelgium segment decrease from EUR800K to EUR0K. Net lossreflects Fair value gains decrease from EUR11.6M (income)to EUR0K, Other Operating Expense increase from EUR9.3M toEUR20.1M (expense). Basic Earnings per Share excludingExtraordinary Items decreased from EUR0.02 to -EUR0.28.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

TIG Revenue Unlock TIG Revenue

Net Income

TIG Net Income Unlock TIG Revenue

Normalised EPS

TIG Normalised EPS Unlock TIG Revenue

PE Ratio Range

TIG PE Ratio Range Unlock TIG Revenue

Dividend Yield Range

TIG Dividend Yield Range Unlock TIG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TIG EPS Forecasts Unlock TIG Revenue
Profile Summary

TiGenix NV is a Belgium-based biopharmaceutical company focused on the development and commercialization of therapeutics from its platforms of allogeneic, or donor-derived, expanded stem cells. The Company's two products from the adipose-derived stem cell platform are in clinical development. Cx601 is in Phase III for the treatment of complex perianal fistulas in Crohn’s disease patients, and Cx611 which has completed a Phase I sepsis challenge trial and a Phase I/II trial in rheumatoid arthritis. From the Company's cardiac stem cell-based platform are AlloCSC-01 with a Phase II clinical trial in Acute Myocardial Infarction, and AlloCSC-02 being developed for a chronic indication. TiGenix NV operates in the domestic market and in Madrid, Spain.

Directors
Last Annual December 31st, 2017
Last Interim December 31st, 2017
Incorporated March 2, 2000
Public Since March 22, 2007
No. of Shareholders: n/a
No. of Employees: 89
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Euronext - Brussels
Shares in Issue 296,067,856
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TIG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TIG
Upcoming Events for TIG
Frequently Asked Questions for Tigenix NV
What is the Tigenix NV share price?

As of 26/07/18, shares in Tigenix NV are trading at €1.78, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Tigenix NV share price performed this year?

Shares in Tigenix NV are currently trading at €1.78 and the price has moved by 94.52% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Tigenix NV price has moved by 75.63% over the past year.

What are the analyst and broker recommendations for Tigenix NV?

Of the analysts with advisory recommendations for Tigenix NV, there are there are currently 0 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Tigenix NV is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Tigenix NV next release its financial results?

Tigenix NV is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-12-31
What is the Tigenix NV dividend yield?

Tigenix NV does not currently pay a dividend.

Does Tigenix NV pay a dividend?

Tigenix NV does not currently pay a dividend.

When does Tigenix NV next pay dividends?

Tigenix NV does not currently pay a dividend.

How do I buy Tigenix NV shares?

To buy shares in Tigenix NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Tigenix NV?

Shares in Tigenix NV are currently trading at €1.78, giving the company a market capitalisation of £n/a.

Where are Tigenix NV shares listed? Where are Tigenix NV shares listed?

Here are the trading details for Tigenix NV:

Country of listing: Belgium
Exchange: BRU
Ticker Symbol: TIG
What kind of share is Tigenix NV?

We were not able to load our ranking data for Tigenix NV

Is there a Tigenix NV share price forecast 2021?

We were not able to load any forecast data for Tigenix NV.

How can I tell whether the Tigenix NV share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tigenix NV. Over the past six months, the relative strength of its shares against the market has been -6.65%. At the current price of €1.78, shares in Tigenix NV are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Tigenix NV PE Ratio?

We were not able to find PE ratio data for Tigenix NV.

Who are the key directors of Tigenix NV?

We were unable to find the directors for Tigenix NV.

Who are the major shareholders of Tigenix NV?

Here are the top five shareholders of Tigenix NV based on the size of their shareholding:

Similar to TIG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.